藤田医科大学 腫瘍医学研究センター（Oncology Innovation Center）は、がんの基礎研究と臨床をつなぐ拠点として、患者さんから得られる腫瘍組織や血液などの検体解析と臨床データを統合し、がんのリスク評価、早期診断、再発検出、治療選択、新規治療法の開発へとつなげることを目指しています。そのために、がんに関する正確かつ最新の情報発信、データ解析（informatics）や機械学習を含む解析手法の活用、さらに研究・診療・データ解析を横断する人材育成を進めることで、研究と診療の質を高め、学内外のがん研究とがん医療の発展に貢献します。

The Oncology Innovation Center (ONIC), Fujita Health University, serves as a hub connecting basic cancer research and clinical practice. By integrating analyses of patient-derived specimens, such as tumor tissues and blood samples, with clinical data, the Center aims to advance cancer risk assessment, early diagnosis, detection of recurrence, selection of appropriate therapies, and the development of new treatments. To achieve these goals, we promote the dissemination of accurate and up-to-date information on cancer, the use of analytical approaches including informatics and machine learning, and the training of professionals who can work across research, clinical practice, and data science. Through these efforts, the Center seeks to enhance the quality of both research and clinical care, while contributing to the advancement of cancer research and oncology both within and beyond the university.